The relationship between patient satisfaction and effectiveness of insulin-based therapy for type 2 diabetes mellitus at Ulin Regional Public Hospital, Banjarmasin

Authors

  • Risya Mulyani Pharmacy Faculty Universitas Muhammadiyah Banjarmasin
  • Dedi Hartanto Faculty of Pharmacy Universitas Muhammadiyah Banjarmasin

DOI:

https://doi.org/10.12928/pharmaciana.v8i1.7633

Keywords:

Diabetes mellitus, therapy satisfaction, and HbA1c value

Abstract

Diabetes Mellitus (DM) can cause significant problems to the quality of life as it may increase the risk of complications. Dissatisfaction with therapy also contributes to its low effectiveness. Therapeutic satisfaction has an essential role in DM management, i.e., to optimize the effectiveness of the treatment. It is also believed to affect the decision-making process regarding patients‘ healthrelated issues. A routine assessment of the satisfaction of DM patients is useful for health professionals in identifying the potential problems experienced by those who are in the middle of DM treatment. This study aimed to determine the relationship between patient satisfaction and effectiveness of insulin-based therapy for type 2 DM at Ulin Regional Public Hospital, Banjarmasin. This research is a nonexperimental study with a cross-sectional design. The data were collected prospectively with purposive sampling method from the type 2 DM patients at the Pharmacy Installation of Ulin Regional Public Hospital, Banjarmasin. While the therapeutic satisfaction data were obtained using the Patient Satisfaction with Insulin Therapy (PSIT) questionnaire, the effectiveness of the therapy was identified by examining the HbA1c values. Fifty-six (56) respondents participated and filled in the questionnaire, and the answers were processed with bivariate analysis, namely the chi-square test. The results showed that the respondents‘ satisfaction with the treatments was mostly on a medium level according to 33 patients (58.9%). However, only 3.6% respondents found the therapy effective (HbA1c <6.5%). The remaining 96.4% thought that it was less effective in controlling diabetes. Based on the statistical analysis results, there is a significantly positive relationship between patient satisfaction and HbA1c value ([r= 0.828]; [p= 0.000]). There is also a significant positive relationship between patient satisfaction and the effectiveness of therapy in patients with type 2 diabetes at the Pharmacy Installation of Ulin Regional Public Hospital, Banjarmasin.

References

American Diabetes Association (ADA) (2017) ‘Standards of Medical Care in Diabetes—2017 : Summary of Revisions’, Diabetes Care, 40(Supplement 1), pp. S4–S5. doi: 10.2337/dc17-S003.

Bardisi, W., Khorsheed, M., Magliah, F. and Magliah, A. (2015) ‘Efficacy of insulin analogues in diabetic patients attending primary care centers’, Saudi Medical Journal, 36(7), pp. 829–833. doi: 10.15537/smj.2015.7.11409.

Black, C., Cummins, E., Royle, P., Philip, S. and Waugh, N. (2006) The clinical effectiveness and cost effectiveness of inhaled insulin in diabetes mellitus : A systematic review and economic evaluation A health technology assessment commissioned by the HTA Programme on behalf of the National Institute for Health and Cli. Aberdeen. Available at: https://www.nice.org.uk/guidance/ta113/documents/diabetes-type-1-and-2-inhaled-insulin-assessment-report2.

Boels, A. M., Vos, R. C., Hermans, T. G. T., Zuithoff, N. P. A., Müller, N., Khunti, K. and Rutten, G. E. H. M. (2017) ‘What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries’, BMJ Open, 7(7), p. e016180. doi: 10.1136/bmjopen-2017-016180.

Gerber, R. A., Cappelleri, J. C., Kourides, I. A. and Gelfand, R. A. (2001) ‘Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.’, Diabetes care, 24(9), pp. 1556–9. doi: 10.2337.

Karnchanasorn, R., Huang, J., Ou, H.-Y., Feng, W., Chuang, L.-M., Chiu, K. C. and Samoa, R. (2016) ‘Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration’, Journal of Diabetes Research, 2016, pp. 1–11. doi: 10.1155/2016/6195494.

Migdalis, I., Leslie, D., Mavrogiannaki, A., Papanas, N., Valensi, P. and Vlassara, H. (2015) ‘Diabetes Mellitus 2014.’, International journal of endocrinology, 2015, p. 845759. doi: 10.1155/2015/845759.

Mora, P., Buskirk, A., Lyden, M., Parkin, C. G., Borsa, L. and Petersen, B. (2017) ‘Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study’, Diabetes Technology & Therapeutics, 19(12), p. dia.2017.0206. doi: 10.1089/dia.2017.0206.

Pengurus Besar Perkumpulan Endokrinologi Indonesia (PB PERKENI) (2015a) Konsensus Pengelolaan dan Pencegahan Diabetes Melitus tipe 2 di Indonesia 2015, Konsensus Pengelolaan dan Pencegahan Diabetes Melitus tipe 2 di Indonesia 2015. Jakarta: PB Perkeni. Available at: http://pbperkeni.or.id/doc/konsensus.pdf.

PERKENI (2015b) Konsensus Penggunaan Insulin. Jakarta: PB PERKENI. Available at: http://pbperkeni.or.id/newperkeni/wp-content/plugins/download-attachments/includes/download.php?id=102.

Ramadhan, N. and Marissa, N. (2015) ‘Karakteristik Penderita Diabetes Melitus Tipe 2 berdasarkan Kadar Hba1c di Puskesmas Jayabaru Kota Banda Aceh’, Sel, 2(2), pp. 49–56. doi: 10.22435/sel.v2i2.4637.49-56.

Tsukube, S., Ikeda, Y., Kadowaki, T. and Odawara, M. (2015) ‘Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study’, Diabetes Therapy. Springer Healthcare, 6(2), pp. 153–171. doi: 10.1007/s13300-015-0111-5.

Umpierrez, G. E., Reyes, D., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Pasquel, F., Jacobs, S., Newton, C., Peng, L. and Fonseca, V. (2014) ‘Hospital Discharge Algorithm Based on Admission HbA 1c for the Management of Patients With Type 2 Diabetes’, Diabetes Care, 37(11), pp. 2934–2939. doi: 10.2337/dc14-0479.

World Health Organization (WHO). (2016) Global Report on Diabetes, Global Report on Diabetes. Geneva, Switzerland: WHO Press. Available at: http://www.who.int.

You, D., Nilsson, E., Tenen, D. E., Lyubetskaya, A., Lo, J. C., Jiang, R., Deng, J., Dawes, B. A., Vaag, A., Ling, C., Rosen, E. D. and Kang, S. (2017) ‘Dnmt3a is an epigenetic mediator of adipose insulin resistance’, eLife, 6, pp. 2–3. doi: 10.7554/eLife.30766.

Downloads

Published

2018-06-02

Issue

Vol. 8 No. 1 (2018): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.